Phoenix Molecular Designs is a biotechnology company based in San Diego, CA, specializing in personalized and alternative cancer therapeutics. With a focus on precision medicine, they aim to improve the lives of cancer patients by delivering tailored treatments based on the genetic composition of their tumors. Their research and development efforts center around patented RSK inhibitors and companion diagnostics for various types of cancer, including those affecting the brain, breast, colon, and prostate.
As a leader in the field of breast cancer drug development, Phoenix Molecular Designs has attracted renowned experts to their team, such as Martin S. Olivo, MD, MSc, who has joined their Advisory Board. With a commitment to advancing cancer treatment, the company recently completed patient enrollment in a Phase 1 1b clinical trial of their promising drug, PMD-026. Through their innovative approach and dedication to precision medicine, Phoenix Molecular Designs is poised to make significant contributions to the fight against cancer.
Generated from the website